CVE:VIV Avivagen (VIV) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free VIV Stock Alerts C$0.0050 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.08Volume2,820 shsAverage Volume49,827 shsMarket CapitalizationC$388,450.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Avivagen alerts: Email Address Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one About Avivagen Stock (CVE:VIV)Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.Read More VIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIV Stock News HeadlinesMarch 6, 2024 | investing.comAvivagen Inc (VIV)March 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - VIVMarch 28, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.February 20, 2024 | theglobeandmail.comAvivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)January 3, 2024 | finance.yahoo.comPure Harvest Corporate Group, Inc. (PHCG)November 5, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Monday (VIV)October 17, 2023 | finance.yahoo.comAvivagen Announces New 500Kg Order for OxC-beta™August 25, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Friday (VIV)March 28, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… July 31, 2023 | technews.tmcnet.comAvivagen Provides Corporate UpdatesJuly 29, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc up on Friday (VIV)July 24, 2023 | finance.yahoo.comAvivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock ProductJuly 19, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Tuesday (VIV)July 15, 2023 | theglobeandmail.comAvivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)June 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Monday (VIV)May 25, 2023 | msn.comAn existing Avivagen customer increases order sizeMay 25, 2023 | finance.yahoo.comAvivagen Announces Significant Increase in Sales to an Existing CustomerMay 23, 2023 | sg.finance.yahoo.comAvivagen Inc. (VIV.V)May 18, 2023 | tmcnet.comAvivagen Announces Review of Strategic AlternativesApril 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Thursday (VIV)April 19, 2023 | finance.yahoo.comAvivagen Announces AGM ResultsApril 7, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Thursday (VIV)April 6, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Wednesday (VIV)March 28, 2023 | finance.yahoo.comAvivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSOMarch 18, 2023 | finance.yahoo.comAvivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)February 21, 2023 | msn.comAvivagen reports FY resultsFebruary 21, 2023 | finance.yahoo.comAvivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate GrowthSee More Headlines Receive VIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VIV CUSIPN/A CIKN/A Webwww.avivagen.com Phone613-949-8164FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,640,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-193.44% Debt Debt-to-Equity Ratio2,402.32 Current Ratio0.03 Quick Ratio0.30 Sales & Book Value Annual SalesC$403,780.00 Price / Sales0.96 Cash FlowC$0.00 per share Price / Cash Flow12.14 Book ValueC($0.10) per share Price / Book-0.05Miscellaneous Outstanding Shares77,690,000Free FloatN/AMarket CapC$388,450.00 OptionableNot Optionable Beta1.21 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. G. F. Kym Anthony (Age 68)CEO & Vice Chairman Comp: $361.06kDr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & DirectorMr. Ira LevyInterim Chief Financial OfficerDr. James Nickerson Ph.D.President and Executive VP of Business Development & Product InnovationMr. Drew BasekDirector of Investor RelationsMs. Tracy Gillett BVSCDirector of Companion Animal & Marketing ManagerMore ExecutivesKey CompetitorsSugarBud Craft GrowersCVE:SUGRNeutriSci InternationalCVE:NUBioasis TechnologiesCVE:BTIImaging DynamicsCVE:IDLKiaroCVE:KOView All Competitors VIV Stock Analysis - Frequently Asked Questions How have VIV shares performed in 2024? Avivagen's stock was trading at C$0.01 at the start of the year. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is Avivagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our VIV earnings forecast. What other stocks do shareholders of Avivagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV). How do I buy shares of Avivagen? Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VIV) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.